Elmer v. Commissioner of Social Security

CourtDistrict Court, W.D. New York
DecidedNovember 15, 2019
Docket6:18-cv-06468
StatusUnknown

This text of Elmer v. Commissioner of Social Security (Elmer v. Commissioner of Social Security) is published on Counsel Stack Legal Research, covering District Court, W.D. New York primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Elmer v. Commissioner of Social Security, (W.D.N.Y. 2019).

Opinion

UNITED STATES DISTRICT COURT WESTERN DISTRICT OF NEW YORK

Elizabeth M. Elmer,

Plaintiff,

v. 18-CV-6468 Decision and Order Commissioner of Social Security,

Defendant.

On June 21, 2018, the plaintiff, Elizabeth M. Elmer, brought this action under the Social Security Act ("the Act"). She seeks review of the determination by the Commissioner of Social Security ("Commissioner") that she was not disabled. Docket Item 1. On February 4, 2019, Elmer moved for judgment on the pleadings, Docket Item 10; on April 5, 2019, the Commissioner responded and cross-moved for judgment on the pleadings, Docket Item 13; and on April 25, 2019, Elmer replied, Docket Item 14. For the reasons stated below, the Court grants Elmer’s motion in part and denies the Commissioner’s cross-motion. BACKGROUND I. PROCEDURAL HISTORY On August 7, 2014, Elmer applied for Supplemental Security Income benefits. Docket Item 8 at 144-53. She claimed that she had been disabled since August 7, 2013, due to depression, anxiety, asthma, stress headaches, and allergies. Id. at 145. On November 21, 2014, Elmer received notice that her application was denied because she was not disabled under the Act. Id. at 66-77. She requested a hearing before an administrative law judge ("ALJ"), id. at 91, which was held on January 31, 2017, id. at 38-64. The ALJ then issued a decision on May 31, 2017, confirming the finding that Elmer was not disabled. Id. at 20-31. Elmer appealed the ALJ’s decision, but her appeal was denied on April 23, 2018, and the decision then became final. Id. at

4-8. II. RELEVANT MEDICAL EVIDENCE The following summarizes the medical evidence most relevant to Elmer’s appeal. Elmer was examined by several different providers, but four—Paul Howe, M.D.; professionals at Evelyn Brandon Center for Mental Health; Harbinder Toor, M.D.; and Adam Brownfield, Ph.D.—are of most significance to the claim of disability here.

A. Paul Howe, M.D. On March 15, 2013, Elmer was evaluated by her primary care physician, Paul Howe, M.D. Id. at 236. Dr. Howe diagnosed abnormal weight loss, dysuria, and pathesias (tingling sensation) of the feet; refilled Elmer’s prescriptions for the antidepressants Trazodone and Remeron; and recommended that Elmer seek

psychiatric care. Id. at 237. Elmer followed up with Dr. Howe on May 10, 2013. Id. at 240. He confirmed his prior diagnoses and added a fourth diagnosis of an unspecified depressive disorder. Id. at 242. On October 16, 2014, Dr. Howe updated his diagnoses to include bilateral lower extremity paresthesia and syncope. Id. at 245. He noted that he also suspected tarsal tunnel syndrome and recommended that Elmer undergo electromyography (“EMG”) to further understand her condition. Id. at 244. Dr. Howe next saw Elmer on August 4, 2016. Id. at 440. Elmer reported “headache, dizziness, neck cracking, armpit pain, forearm pain, hand pain, wrist pain, weight loss, hip pain, menstrual pain, eye itching, sinus pressure, right upper medial thigh pain, foot pain, back pain, and acid reflux.” Id. Dr. Howe renewed Elmer’s

Remeron prescription; encouraged her to reconnect with her psychiatric providers; and recommended ibuprofen and physical therapy for back pain, Zantac for allergies and gastroesophageal reflux disease complaints, and an X-ray to determine whether she had a fracture in her left foot. Id. at 442. B. Evelyn Brandon Center for Mental Health In October 2013, Elmer established care at the Evelyn Brandon Center for

Mental Health. Starting on November 12, 2013, and ending on June 11, 2015, she received biweekly individual counseling from Cheryl Chiappone, L.M.H.C., to address her diagnoses of an unspecified mood disorder, an unspecified anxiety disorder, borderline personality disorder, an unspecified depressive disorder, and cannabis dependence. See, e.g., id. at 413, 477. Although Elmer missed a number of appointments, the record shows that she was present for at least 23 sessions over this nineteen-month period. See id. at 252-425. Elmer’s October 21, 2015 discharge papers note that Elmer reportedly stopped treatment due to a lapse in insurance coverage. Id. at 252.

Elmer also was seen by at least three different psychiatrists at Evelyn Brandon. On February 13, 2014, psychiatrist Gerhardt S. Wagner, M.D./Ph.D., noted that Elmer reported worsening anxiety that “ma[de] it difficult to leave [her] house.” Id. at 220. He prescribed the antidepressant Remeron and the antianxiety medication hydroxyzine. Id. On June 5, 2014, psychiatrist Prakesh P. Reddy, M.D., noted paranoid ideation, a depressed mood, and poor concentration and memory. He prescribed the antidepressants Remeron and Effexor. Id. at 374. Dr. Reddy again prescribed both medications on September 24, 2014, and October 22, 2014. Id. at 324-26.

On April 9, 2015, psychiatrist Stephanie Beneski-Barlow, D.O., evaluated Elmer. Elmer reported that she had stopped treatment because she “couldn’t make [herself] come” and that “in the last several months she ha[d]n’t been leaving her house and sometimes . . . would keep her children home from school.” Id. at 286. Dr. Beneski- Barlow noted that Elmer was anxious and depressed, prescribed Remeron, and recommended that Elmer engage in individual and group therapy. Id. at 287, 289. Elmer followed up with Dr. Beneski-Barlow on June 3, 2015. Elmer reported that “lately her mood ha[d] been ‘pretty good,’” but that she was “unsure if she wanted to engage in group therapy because ‘it [would] make [her] anxiety worse.’” Id. at 262. Dr. Beneski- Barlow continued her Remeron prescription and also started Elmer on the

anticonvulsant/anti-anxiety medication Gabapentin. Id. Elmer reestablished care at Evelyn Brandon in January 2017. Jay Pruiett, L.C.S.W., performed a comprehensive psychosocial evaluation of Elmer on February 9, 2017. Id. at 470-73. He diagnosed an unspecified mood disorder and borderline personality disorder. Id. at 470. Elmer then followed up with William Benton, M.H.C., for counseling on February 23, 2017, and March 6, 2017. Id. at 476-84. Mr. Benton noted that Elmer’s thought coherency, concentration, and attention were all within normal limits; that she expressed no delusions or other psychotic content; and that her recent and remote memory were “[i]ntact.” See id. at 477-78, 481-82. C. Harbinder Toor, M.D. On November 5, 2014, neurologist Harbinder Toor, M.D., performed a consultative internal medicine examination of Elmer. Id. at 229-33. Dr. Toor noted that Elmer had a normal gait but had difficulty walking, getting on and off the examination table, and changing for the exam. Id. at 231. He found that she had full range of

motion in her shoulders, elbows, forearms, wrists, hips, knees, and ankles but noted that Elmer reported tingling and numbness in her toes and hands. Id. at 231-32. He also found that her “finger dexterity [was] not intact in both hands.” Id. at 232. He concluded that Elmer had “mild-to-moderate limitation doing fine motor activity with the hands”; had “moderate limitation[s] standing, walking, bending, and lifting”; and “should avoid irritants or other factors which can precipitate asthma.” Id. at 232. Finally, he opined that headaches could “interfere with [Elmer’s] routine.” Id.

D. Adam Brownfield, Ph.D. On November 5, 2014, psychologist Adam Brownfield, Ph.D., performed a consultative psychological evaluation of Elmer. Id. at 223-27. He found that she had an anxious affect, dysthymic mood, intact attention and concentration, impaired recent and remote memory skills, and good insight and judgment. Id. at 225. He diagnosed generalized anxiety disorder, possible agoraphobia, an unspecified obsessive compulsive disorder, major depressive disorder (moderate), and unspecified cannabis use, and he recommended that Elmer continue with psychological and psychiatric

treatment. Id. at 226. Dr.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Richardson v. Perales
402 U.S. 389 (Supreme Court, 1971)
Bowen v. Yuckert
482 U.S. 137 (Supreme Court, 1987)
Moran v. Astrue
569 F.3d 108 (Second Circuit, 2009)
Zabala v. Astrue
595 F.3d 402 (Second Circuit, 2010)
Ceballos v. Bowen
649 F. Supp. 693 (S.D. New York, 1986)
Smith v. Bowen
687 F. Supp. 902 (S.D. New York, 1988)
Stadler v. Barnhart
464 F. Supp. 2d 183 (W.D. New York, 2006)
Ferraris v. Heckler
728 F.2d 582 (Second Circuit, 1984)
Johnson v. Bowen
817 F.2d 983 (Second Circuit, 1987)

Cite This Page — Counsel Stack

Bluebook (online)
Elmer v. Commissioner of Social Security, Counsel Stack Legal Research, https://law.counselstack.com/opinion/elmer-v-commissioner-of-social-security-nywd-2019.